Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 68071-2215

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 68071-2215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2215 4)

Label for Pantoprazole Sodium 40 mg delayed-release tablets by NuCare Pharmaceuticals, Inc. This prescription drug package contains 14 tablets. The label includes drug identification with NDC 68071-2215-4 and product number P1782014. Instructions for use, manufacturer information from Menarini, and storage warnings are visible, along with dosage and imprint details.*

FDA Label Image

Address1.jpg (Address1)

FDA Label Image

Address2.jpg (Address2)

FDA Label Image

Structure.jpg (Structure)

Chemical structure of pantoprazole, the active ingredient in PANTOPRAZOLE SODIUM 40 mg delayed-release tablets by NuCare Pharmaceuticals, Inc. This diagram shows the molecular arrangement including functional groups and sodium ion associated with the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.